Page 51 - Genentech News Today

Advances in artificial intelligence are at the heart of many of this year’s most exciting areas of technological innovation Advances in artificial intelligence are at the heart of many of this year’s most exciting areas of technological innovation

By David Sachs Sandoz said that it will buy vision-impairment drug Cimerli from Coherus BioSciences for $170 million. The Swiss pharmaceutical company said...

Since 2022, the Initiative to Advance Decentralized Clinical Trials (the Initiative) has come together to identify issues and policy opportunities to advance decentralized clinical trials (DCTs).

What does it all mean? Well, to be honest it was nice to be at the game, even if my team lost, while the first wave of coverage broke. I was with a great group of guys, all of whom care about the industry and who have opinions, some of...

Global Lymphoproliferative Disorder Treatment Market Analysis (2019 - 2030)

In light of the 2023 Supreme Court of the United States decision in Amgen Inc. v. Sanofi, the US Patent & Trademark Office (PTO) published guidelines for PTO employees to use,...

/PRNewswire/ -- Kazia Therapeutics Limited (NASDAQ: KZIA), an oncology-focused drug development company, is pleased to announce the appointment of pharma...

/PRNewswire/ -- Global Oncology Precision Medicine Market Overview The global oncology precision medicine market is growing exponentially; it is estimated to...

"Academy companies" produce first-rate executives who populate their own senior ranks and also go on to lead other companies.

AARP’s findings reflect a world prior to the passage and enactment of the Inflation Reduction Act of 2022, which requires drug manufacturers to pay rebates to Medicare if their drug prices increase faster than inflation.